Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome – Oncology Nurse Advisor
Oncology Nurse Advisor |
Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
Oncology Nurse Advisor Patients with MDS produce insufficient amounts of healthy blood cells. “Although donor stem cell transplantation is the only curative therapy for MDS, many patients die after transplantation, largely due to relapse of the disease or complications … |
Business Insider UK |
A US panel has endorsed limited genetic modification of humans — here’s what that means
Business Insider UK For now it’s hard to apply a genetic editing tool (like CRISPR) to an early embryo and have it make all the changes to a genome that you want (and no unwanted extra changes). When you let that editing tool loose it seeks out the segments of DNA you are … |
Business Insider |
National Academies Panel says some germline editing with CRISPR …
Business Insider These are the sort of conditions scientists have said it’s permissible to edit human genomes for and what will have to happen before that becomes a reality. |
|
Cx601 stem cell therapy maintains remission of complex perianal fistulas through 1 year in Crohn’s
Healio Patients with Crohn’s disease achieved sustained remission of treatment-refractory complex perianal fistulas through 52 weeks after treatment with Cx601 stem cell therapy, according to results from the ADMIRE-CD trial presented at the 12th Congress of … |
|
Cx601 stem cell therapy maintains remission of complex perianal fistulas through 1 year in Crohn’s
Healio Patients with Crohn’s disease achieved sustained remission of treatment-refractory complex perianal fistulas through 52 weeks after treatment with Cx601 stem cell therapy, according to results from the ADMIRE-CD trial presented at the 12th Congress of … |